Learning from the Experience of the COVID-19 Pandemic: A New Paradigm for Occupational Biohazard Assessment and Management

Contenuto principale dell'articolo

La Redazione
Alborz Rahmani
Alfredo Montecucco
Guglielmo Dini

Keywords

Abstract

The COVID-19 pandemic has affected workplaces in many different aspects. In this scenario, Occupational Physicians played a crucial role in assessing and managing the risk of SARS-CoV-2 infection and associated diseases to guarantee workers' health and the safety of workplaces. However, the pandemic experience has drawn attention to several critical issues in overall biohazard prevention and management strategies, originating from important knowledge gaps in our scientific understanding.
An extensive analysis of the relevant hurdles that have emerged in our medical field can bring valuable lessons for the post pandemic future, not only in preparation for possible new pathogens with pandemic potential but also with principles and concepts applicable to managing all biological agents. In particular, a paradigm shift is needed to properly approach occupational diseases caused by infective agents, accurately define the “case”, assess exposure and possible causal relationship with work appropriately, and effectively manage the specific risk through implementing appropriate preventive and protective measures. In this framework, the Occupational Physician should expand his contribution based on his unique expertise and specific competencies, confirming his role as the go-to consultant in all occupational health matters, but also in a multidisciplinary approach, considering different scientific expertise and evidence.
Abstract 236 | PDF (Inglese) Downloads 281

Riferimenti bibliografici

1. European Centre for Disease Prevention and Control. COVID-19 clusters and outbreaks in occupational settings in the EU/EEA and the UK. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-in-occupational-settings.pdf [Last Ac-cessed on 20 November 2023]
2. Istituto Nazionale per l'Assicurazione contro gli Infortuni sul Lavoro (INAIL). Scheda nazionale infortuni sul la-voro da COVID-19. I dati sulle denunce da COVID-19 al 30 aprile 2023. NR. 32 – APRILE 26 maggio 2023. Available online: https://www.inail.it/cs/internet/docs/alg-scheda-tecnica-contagi-covid-30-aprile-2023.pdf?section=comunicazione [Last Accessed on 20 November 2023]
3. Mutti A. Occupational Medicine in the time of COVID-19. Med Lav. 2020;111(2):83-86. Doi: 10.23749/mdl.v111i2.9546
4. Spencer E, Jefferson T, Brassey J, Heneghan C. When is Covid, Covid? The Centre for Evidence-Based Medicine. September 11, 2020. Available online: https://www.cebm.net/covid-19/when-is-covid-covid/ [Last Accessed on 20 November 2023]
5. Velavan TP, Meyer CG. COVID-19: A PCR-defined pandemic. Int J Infect Dis. 2021;103:278-279. Doi: 10.1016/j.ijid.2020.11.189
6. Mahase E. Covid-19: the problems with case counting. BMJ. 2020;370:m3374. Published 2020 Sep 3. Doi: 10.1136/bmj.m3374
7. Xu J, Cao B. Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19. Eur Respir J. 2022;59(1):2102002. Doi: 10.1183/13993003.02002-2021
8. Neo WL, Ng JCF, Iyer NG. The great pretender-Bell's palsy secondary to SARS-CoV-2? Clin Case Rep. 2021;9(3):1175-1177. Doi: 10.1002/ccr3.3716
9. Nigro M, Chalmers JD, Aliberti S. A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet. Eur Respir J. 2023;61(4):2300270. Doi: 10.1183/13993003.00270-2023
10. Verbeek J. When Work is Related to Disease, What Establishes Evidence for a Causal Relation? Saf Health Work. 2012;3(2):110-116. Doi: 10.5491/SHAW.2012.3.2.110
11. Wu Y, Kang L, Guo Z, Liu J, Liu M, Liang W. Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 Strains: A Systematic Review and Meta-analysis [published correction appears in JAMA Netw Open. 2022 Sep 1;5(9):e2235424]. JAMA Netw Open. 2022;5(8):e2228008. Doi: 10.1001/jamanetworkopen.2022.28008
12. Madewell ZJ, Yang Y, Longini IM Jr, Halloran ME, Vespignani A, Dean NE. Rapid review and meta-analysis of se-rial intervals for SARS-CoV-2 Delta and Omicron variants. BMC Infect Dis. 2023;23(1):429. Doi: 10.1186/s12879-023-08407-5
13. European Centre for Disease Prevention and Control. Novel coronavirus (SARS-CoV-2) - Discharge criteria for confirmed COVID-19 cases – When is it safe to discharge COVID-19 cases from the hospital or end home isola-tion? – 28 February 2020. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-Discharge-criteria.pdf [Last Accessed on 20 November 2023]
14. Atkinson B, Petersen E. SARS-CoV-2 shedding and infectivity. Lancet. 2020;395(10233):1339-1340. Doi: 10.1016/S0140-6736(20)30868-0
15. Jefferson T, Spencer EA, Brassey J, Heneghan C. Viral cultures for COVID-19 infectious potential assessment – a systematic review. Clin Infect Dis. 2020;ciaa1764. Doi: 10.1093/cid/ciaa1764
16. Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Na-ture. 2020; 581(7809):465-469. Doi: 10.1038/s41586-020-2196-x
17. Centers for Disease Control and Prevention. Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2. Available online: https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html [Last Accessed on 20 November 2023]
18. Ministero della Salute. COVID-19: indicazioni per la durata ed il termine dell’isolamento e della quarantena. Circular n. 32850 on 12/10/2020. Available on-line: http://www.normativasanitaria.it/jsp/dettaglio.jsp?id=76613 [Last Accessed on 20 November 2023]
19. Ministero della Salute. Aggiornamento delle modalità di gestione dei casi e dei contatti stretti di caso COVID-19. Circular n. 51961 on 31/12/2022. Available on-line: https://www.trovanorme.salute.gov.it/norme/dettaglioAtto?id=91258 [Last Accessed on 20 November 2023]
20. Ministero della Salute. Indicazioni per la riammissione in servizio dei lavoratori dopo assenza per malattia Co-vid-19 correlata. Circular n. 15127 on 12/04/2021. Available online: http://www.normativasanitaria.it/jsp/dettaglio.jsp?id=79702 [Last Accessed on 20 November 2023]
21. Rahmani A, Dini G, Leso V, et al. Duration of SARS-CoV-2 shedding and infectivity in the working age population: a systematic review and meta-analysis. Med Lav. 2022;113(2):e2022014. Doi: 10.23749/mdl.v113i2.12724
22. Zisook RE, Monnot A, Parker J, Gaffney S, Dotson S, Unice K. Assessing and managing the risks of COVID-19 in the workplace: Applying industrial hygiene (IH)/occupational and environmental health and safety (OEHS) frameworks. Toxicol Ind Health. 2020;36(9):607-618. Doi: 10.1177/0748233720967522
23. Górny RL. Microbial aerosols: sources, properties, health effects, exposure assessment—a review. KONA 37: 64-84, 2020. Doi: 10.14356/ kona.2020005
24. Carvalhais C, Querido M, Pereira CC, Santos J. Biological risk assessment: A challenge for occupational safety and health practitioners during the COVID-19 (SARS-CoV-2) pandemic. Work. 2021;69(1):3-13. Doi: 10.3233/WOR-205302
25. Istituto Superiore di Sanità. Impatto della vaccinazione e della pregressa diagnosi sul rischio di malattia grave associata a SARS-CoV-2. Mese di riferimento dei casi: 02/01/2023 – 05/02/2023 Data di pubblicazione: 21/04/2023. Available online: https://www.epicentro.iss.it/coronavirus/pdf/COVID-19_Report%20analisi%20del%20rischio%20-%2021042023.pdf [Last Accessed on 20 November 2023]
26. NIOSH [2019]. Technical report: The NIOSH occupational exposure banding process for chemical risk manage-ment. By Lentz TJ, Seaton M, Rane P, Gilbert SJ, McKernan LT, Whittaker C. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2019-132, Doi: https://doi.org/10.26616/NIOSHPUB2019132
27. Roger D. Lewis and Robert Strode, Senior Editors. American Industrial Hygiene Association (AIHA). The Role of the Industrial Hygienist in a Pandemic 2nd Edition. September 1, 2021. Available online: https://aiha-assets.sfo2.digitaloceanspaces.com/AIHA/resources/Role-of-the-Industrial-Hygienist-in-a-Pandemic-2nd-edition.pdf [Last Accessed on 20 November 2023]
28. Sietsema M, Radonovich L, Hearl FJ, et al. A Control Banding Framework for Protecting the US Workforce from Aerosol Transmissible Infectious Disease Outbreaks with High Public Health Consequences. Health Secur. 2019;17(2):124-132. Doi: 10.1089/hs.2018.0103
29. Montecucco A, Dini G, Rahmani A, et al. Investigating SARS-CoV-2 transmission among co-workers in a University of Northern Italy during COVID-19 pandemic: an observational study. Med Lav. 2021;112(6):429-435. Doi: 10.23749/mdl.v112i6.12527
30. Drossinos Y, Weber TP, Stilianakis NI. Droplets and aerosols: An artificial dichotomy in respiratory virus trans-mission. Health Sci Rep. 2021;4(2):e275. Doi: 10.1002/hsr2.275
31. Bourouiba L. Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19. JAMA. 2020;323(18):1837-1838. Doi: 10.1001/jama.2020.4756
32. Conly J, Seto WH, Pittet D, et al. Use of medical face masks versus particulate respirators as a component of per-sonal protective equipment for health care workers in the context of the COVID-19 pandemic [published correc-tion appears in Antimicrob Resist Infect Control. 2020 Sep 9;9(1):151]. Antimicrob Resist Infect Control. 2020;9(1):126. Doi: 10.1186/s13756-020-00779-6
33. Chen W, Zhang N, Wei J, Yen HL, Li Y. Short-range airborne route dominates exposure of respiratory infection during close contact. Build. Environ. 2020;176. Doi: 10.1016/j.buildenv.2020.106859
34. Ciocan C, Clari M, Fabbro D, et al. Impact of wearing a surgical mask on respiratory function in view of a wide-spread use during COVID-19 outbreak. A case-series study. Med Lav. 2020;111(5):354-364. Doi: 10.23749/mdl.v111i5.97662
35. Violante T, Violante FS. Surgical masks vs respirators for the protection against coronavirus infection: state of the art. Med Lav. 2020;111(5):365-371. Doi: 10.23749/mdl.v111i5.96923
36. Cacco T, Fragale M, Sampieri C, et al. Modified full-face snorkeling mask for thoracic surgery and otolaryngology surgical use: comfort and usability assessment during the COVID-19 pandemic. Med Lav. 2021;112(2):107-114. Doi: 10.23749/mdl.v112i2.100324
37. Collatuzzo G, Mansour I, Ciocan C, et al. Effectiveness of prevention of SARS-CoV-2 transmission among unvac-cinated Italian healthcare workers. Med Lav. 2022;113(6):e2022050. Doi: 10.23749/mdl.v113i6.135775
38. Mansour I, Godono A, Sansone E, et al. Factors Associated with SARS-CoV-2 Infection before Vaccination among European Health Care Workers. Med Lav. 2023;114(3):e2023022. Doi: 10.23749/mdl.v114i3.14422
39. Chou R, Dana T. Major Update: Masks for Prevention of SARS-CoV-2 in Health Care and Community Set-tings-Final Update of a Living, Rapid Review. Ann Intern Med. 2023;176(6):827-835. Doi: 10.7326/M23-0570
40. Greenhalgh T, Fisman D, Cane DJ, Oliver M, Macintyre CR. Adapt or die: how the pandemic made the shift from EBM to EBM+ more urgent. BMJ Evid Based Med. 2022;27(5):253-60. Doi: 10.1136/bmjebm-2022-111952
41. Istituto Superiore di Sanità. Nota Tecnica - Indicazioni ad interim per un utilizzo appropriato delle protezioni per infezione da SARS-CoV-2 nelle attività sanitarie e sociosanitarie. Aggiornato al 27 maggio 2022.
42. Bobrovitz N, Ware H, Ma X, et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis. 2023;23(5):556-567. Doi:10.1016/S1473-3099(22)00801-5
43. Porru S, Monaco MGL, Spiteri G, et al. Incidence and Determinants of Symptomatic and Asymptomatic SARS-CoV-2 Breakthrough Infections After Booster Dose in a Large European Multicentric Cohort of Health Work-ers-ORCHESTRA Project. J Epidemiol Glob Health. 2023;13(3):577-588. Doi: 10.1007/s44197-023-00139-8
44. European Centre for Disease Prevention and Control. COVID-19 Vaccine Tracker. 9 November 2023. Available online: https://www.ecdc.europa.eu/en/publications-data/covid-19-vaccine-tracker [Last Accessed on 20 No-vember 2023]
45. Apostoli P, Imbriani M. Il Medico del Lavoro, consulente globale per la tutela della salute dei lavoratori. G Ital Med Lav Erg. 2013;35:1,5-9.
46. Apostoli P. The Evolving Work Landscape and the Intersection of Technics, Technology, and Occupational Health. Med Lav. 2023;114(5):e2023045. Doi: 10.23749/mdl.v114i5.15260
47. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.